drugset
drugset / Trial / NCT04667013

A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of TBN

NCT04667013 ↗

Phase 1 Not yet recruiting 16 enrolled Guangzhou Magpie Pharmaceuticals Co., Ltd.
RandomizedSequentialDouble-blindTreatment

Summary

The purpose of this study is to assess the safety, tolerability and pharmacokinetics (i.e. how study drug is taken up by the body) of TBN in healthy participants.

Timeline

Start
2025-09-01
Primary completion
2026-03-31
Completion
2026-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Tetramethylpyrazine nitrone Unknown 600 mg Oral
Subject Tetramethylpyrazine nitrone Unknown 1200 mg Oral

Indications

No indication recorded.